Reducing the cost of quality with the Agilent Vaya Raman system
With profit margins in the pharmaceutical industry under ever increasing pressure, manufacturing groups are incentivized to…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
High incident cases of invasive pneumococcal disease in India is result of lack of country-wide…
Vaccination for pneumococcal disease was only introduced in children in late 2017 across three Indian states, and vaccination in…
Fortifying defence against zoonoses
Express Pharma series on the key pillars of a strategic framework to tackle zoonotic diseases
Coping with COVID-19: AGI glaspac
Dealing with hampered production and lack of input raw materials, AGI glaspac has put in measures to cushion the blow. For…
COVID-19 lockdown affects pharma production in Uttarakhand as companies report low attendance
The DMAU has sought clarification on the government's earlier issued order that all employees will be paid full salaries during…
Takeda Appoints New Country Head for India
Koki Sato, a seasoned biopharmaceutical leader with over 17 years of experience across geographies has been assigned as the new…
Biocon’s Insulin Manufacturing Facility in Malaysia Receives EIR from US FDA
The Inspection has been closed with a “VAI” (Voluntary Action Indicated) classification in the EIR, for the three observations…
Reducing India’s Import Dependence on APIs: A possible way out
Reji K Joseph, Associate Professor at Institute for Studies in Industrial Development, New Delhi writes about how different bodies…
A wake-up call for One Health
As an important stakeholder of global health security, it is time for the pharma sector to embrace newer approaches and strategies…
DGFT defers track and trace deadline for pharma exports to October 1, 2020
MSMEs, SSIs continue to find it difficult to maintain a 'parent-child' relationship at the packaging level and uploading on…